HepaLife(TM) Enters Into New Cooperative Research and Development Agreement with U.S. Government Agency
HepaLife(TM) Announces Exclusive License Agreement with U.S. Government Agency for Liver Cell Lines
HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver
Internationally Renowned Artificial Organs Expert Joins HepaLife(TM)
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
HepaLife Completes Private Placement for $2.5 Million
